NNC0519-0130
A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 Diabetes
Novo Nordisk · Phase 1 · Completed · Enrollment 82
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.